Therapeutic options following second-line platinum-based chemotherapy in patients with recurrent ovarian cancer: comparison of active surveillance and maintenance treatment

Ovarian cancer is the eighth leading cause of death from cancer in women worldwide, with an estimated 185,000 deaths in 2018, representing 4% of all cancer deaths in women [1]. The relapsing nature of the disease has a profound impact on patients and their quality of life (QoL).
Source: Cancer Treatment Reviews - Category: Cancer & Oncology Authors: Tags: Anti-tumour Treatment Source Type: research